The Coronary Drug Project. Experimental design features.
作者信息
Canner P L, Klimt C R
出版信息
Control Clin Trials. 1983 Dec;4(4):313-32. doi: 10.1016/0197-2456(83)90019-3.
PMID:6675887
Abstract
摘要
相似文献
1
The Coronary Drug Project. Experimental design features.
Control Clin Trials. 1983 Dec;4(4):313-32. doi: 10.1016/0197-2456(83)90019-3.
2
Brief description of the Coronary Drug Project and other studies.
Control Clin Trials. 1983 Dec;4(4):273-80. doi: 10.1016/0197-2456(83)90017-x.
3
The Coronary Drug Project. Role and methods of the clinical centers.
Control Clin Trials. 1983 Dec;4(4):419-27. doi: 10.1016/0197-2456(83)90026-0.
4
The FDA's critique of the anturane reinfarction trial.
N Engl J Med. 1980 Dec 18;303(25):1488-92. doi: 10.1056/NEJM198012183032534.
5
Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
JAMA. 1985 Apr 12;253(14):2091-3.
6
The Coronary Drug Project. Monitoring of the data for evidence of adverse or beneficial treatment effects.
Control Clin Trials. 1983 Dec;4(4):467-83. doi: 10.1016/0197-2456(83)90029-6.
7
Dropouts and missing data in psychiatric clinical trials.
Am J Psychiatry. 2009 Nov;166(11):1295; author reply 1295-6. doi: 10.1176/appi.ajp.2009.09070959.
8
Low dose aspirin after early thrombolysis in anterior wall acute myocardial infarction.
Am J Cardiol. 1988 Apr 15;61(11):904-6. doi: 10.1016/0002-9149(88)90368-2.
9
10
Early termination of clinical trials with prolonged observation of individual patients: a case study.
Stat Med. 1987 Dec;6(8):927-37. doi: 10.1002/sim.4780060807.
Zotero 插件